Spinal Cord Injury News and Research

RSS

A spinal cord injury usually begins with a sudden, traumatic blow to the spine that fractures or dislocates vertebrae. The damage begins at the moment of injury when displaced bone fragments, disc material, or ligaments bruise or tear into spinal cord tissue. Most injuries to the spinal cord don't completely sever it. Instead, an injury is more likely to cause fractures and compression of the vertebrae, which then crush and destroy the axons, extensions of nerve cells that carry signals up and down the spinal cord between the brain and the rest of the body. An injury to the spinal cord can damage a few, many, or almost all of these axons. Some injuries will allow almost complete recovery. Others will result in complete paralysis.

Geron's GRNOPC1 Phase 1 trial results on spinal cord injury presented at international conferences

Geron Corporation today announced two presentations on the company's ongoing Phase 1 clinical trial of the human embryonic stem cell-based therapy, GRNOPC1, in patients with spinal cord injury.

7 Jun 2011

AMPYRA ER Tablets improve walking ability in patients with multiple sclerosis

Acorda Therapeutics, Inc. today announced an analysis of pooled clinical trial results showed patients who were responders to AMPYRA (dalfampridine) Extended Release Tablets, 10 mg demonstrated clinically relevant improvements in walking ability as measured by patient self-report on the 12-Item Multiple Sclerosis Walking Scale (MSWS-12), regardless of either their baseline Expanded Disability Status Scale (EDSS) score or baseline walking speed.

7 Jun 2011

Consumer groups, market experts support repeal of Medicare bidding program

Providers of home medical equipment and services in Oregon support H.R. 1041, a bipartisan bill in Congress that would repeal the controversial Medicare "competitive" bidding program for certain medically required equipment and services used at home.

4 Jun 2011

Wireless near-infrared spectroscopy can effectively detect bladder disease in children

A cell phone-sized, wireless near-infrared device is as reliable as the current "gold standard" invasive tests in determining bladder disease, according to a study by researchers at the University of British Columbia, Vancouver Coastal Health and the Child & Family Research Institute (CFRI).

1 Jun 2011

PPSC, InVivo enter sponsorship deal to support Adaptive Sailing Program for the disabled

InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today announced that the Company has entered into a sponsorship agreement with Boston-based Piers Park Sailing Center to support a non-profit sailing initiative for the disabled.

25 May 2011

Scientists direct embryonic, induced human stem cells to become astrocytes in lab dish

Pity the lowly astrocyte, the most common cell in the human nervous system. Long considered to be little more than putty in the brain and spinal cord, the star-shaped astrocyte has found new respect among neuroscientists who have begun to recognize its many functions in the brain, not to mention its role in a range of disorders of the central nervous system.

23 May 2011

Paralyzed man walks again

Three years ago, baseball champion Rob Summers was hit by a speeding car in Portland, Oregon which smashed into his legs and left him with appalling injuries. He was told he would spend the rest of his life in a wheelchair at best. However the 25 year old has become the first person paralyzed from the chest down to stand and take a step unaided.

22 May 2011

Stimulating electrode array assists paralyzed man to regain voluntary movements of limbs

A team of researchers from the University of California, Los Angeles (UCLA), the California Institute of Technology (Caltech), and the University of Louisville have used a stimulating electrode array to assist a paralyzed man to stand, step on a treadmill with assistance, and, over time, to regain voluntary movements of his limbs.

21 May 2011

Breakthrough reason for cautious hope among those with spinal cord injuries

A team of scientists at the University of Louisville, UCLA and the California Institute of Technology has achieved a significant breakthrough in its initial work with a paralyzed male volunteer at Louisville's Frazier Rehab Institute - the result of 30 years of research to find potential clinical therapies for paralysis.

21 May 2011

EMA CHMP recommends conditional marketing authorization of FAMPYRA

The Committee for Medicinal Products for Human Use of the European Medicine Agency has recommended conditional marketing authorization of FAMPYRA (prolonged-release fampridine 10 mg tablets) for the improvement of walking in adult patients with multiple sclerosis with walking disability.

20 May 2011

InVivo Therapeutics reports net loss of $1,278,000 for first quarter 2011

InVivo Therapeutics, a medical device company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today reported financial results for the first quarter 2011.

16 May 2011

Relay stent-graft safe and effective for patients with aortic dissections

Aortic dissection is rare, but when it occurs, a patient's prognosis can be poor, even with timely medical diagnosis and treatment. It is the most frequently diagnosed lethal condition of the aorta.

12 May 2011

Engineers develop novel hybrid HMI for hands-free control of electric powered wheelchairs

For people with severe physical disabilities, such as spinal cord injury, quadriplegia and hemiplegia or amputation, current technology for controlling a wheelchair or mobility scooter is wholly inadequate.

11 May 2011

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Researchers at Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine and The Rehabilitation Institute of Chicago (RIC) recently enrolled their first subject in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury.

11 May 2011

Geron comments on recent European telomerase peptide cancer vaccine patents

Geron Corporation today commented on a ruling from the European Patent Office with regard to its European patent 084139, and the issuance of a second Geron patent covering telomerase peptides, EP1783139.

10 May 2011

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine why human embryonic stem cells are susceptible to forming tumors.

10 May 2011

Zynex first quarter net revenue increases 36% to $6,633,000

Zynex, Inc., a provider of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announces its first quarter 2011 financial results.

5 May 2011

Acorda reports $0.7 million GAAP net loss for first quarter 2011

Acorda Therapeutics, Inc. today announced its financial results for the first quarter ended March 31, 2011.

5 May 2011

The Miami Project, InVivo Therapeutics collaborate to develop novel spinal cord injury treatments

InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, and The University of Miami Miller School of Medicine's Miami Project to Cure Paralysis, the world's most comprehensive spinal cord injury research center, today announced a strategic research collaboration for the development of novel SCI treatments.

5 May 2011

Researchers develop novel spinal cord injury treatment

Rutgers researchers have developed an innovative new treatment that could help minimize nerve damage in spinal cord injuries, promote tissue healing and minimize pain.

4 May 2011

Spinal Cord Injury News and Research

Further Reading

Geron's GRNOPC1 Phase 1 trial results on spinal cord injury presented at international conferences

AMPYRA ER Tablets improve walking ability in patients with multiple sclerosis

Consumer groups, market experts support repeal of Medicare bidding program

Wireless near-infrared spectroscopy can effectively detect bladder disease in children

PPSC, InVivo enter sponsorship deal to support Adaptive Sailing Program for the disabled

Scientists direct embryonic, induced human stem cells to become astrocytes in lab dish

Paralyzed man walks again

Stimulating electrode array assists paralyzed man to regain voluntary movements of limbs

Breakthrough reason for cautious hope among those with spinal cord injuries

EMA CHMP recommends conditional marketing authorization of FAMPYRA

InVivo Therapeutics reports net loss of $1,278,000 for first quarter 2011

Relay stent-graft safe and effective for patients with aortic dissections

Engineers develop novel hybrid HMI for hands-free control of electric powered wheelchairs

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Geron comments on recent European telomerase peptide cancer vaccine patents

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

Zynex first quarter net revenue increases 36% to $6,633,000

Acorda reports $0.7 million GAAP net loss for first quarter 2011

The Miami Project, InVivo Therapeutics collaborate to develop novel spinal cord injury treatments

Researchers develop novel spinal cord injury treatment

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News